A pilot study of ISIS 2302, an antisense oligodeoxynucleotide, in patients with active rheumatoid arthritis.

被引：0
|
作者：
Maksymowych, W
Blackburn, W
Hutchings, E
Williams, L
Tami, J
Wagner, K
Edmonton, WS
机构：
来源：
ARTHRITIS AND RHEUMATISM | 1999年 / 42卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
599
引用
收藏
页码：S170 / S170
页数：1
相关论文
共 50 条
  • [1] Synovial biomarker study of ISIS 104838, an antisense oligodeoxynucleotide targeting TNF-alpha, in rheumatoid arthritis.
    Wei, N
    Fiechtner, J
    Boyle, D
    Kavanaugh, A
    Delauter, S
    Rosengren, S
    Firestein, GS
    Tami, J
    Yu, R
    Sewell, L
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S133 - S133
  • [2] Phase I safety and pharmacokinetic profile of an intercellular adhesion molecule-1 antisense oligodeoxynucleotide (ISIS 2302)
    Glover, JM
    Leeds, JM
    Mant, TGK
    Amin, D
    Kisner, DL
    Zuckerman, JE
    Geary, RS
    Levin, AA
    Shanahan, WR
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1997, 282 (03) : 1173 - 1180
  • [3] Phase 1 study of an ICAM-1 antisense oligonucleotide (ISIS 2302)
    Shanahan, W
    Glover, J
    Mant, T
    Amin, D
    Leeds, J
    Zuckerman, J
    Levin, A
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (02) : PII80 - PII80
  • [4] A pilot phase 2 clinical study on imaging inflamed joints in patients with rheumatoid arthritis.
    Bossuyt, A
    Caveliers, V
    Thornback, JR
    Goodbody, AE
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) : 194P - 194P
  • [5] Cyclosporine combined with sulphasalazine or methotrexate: A pilot study in rheumatoid arthritis.
    LeirisaloRepo, M
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 977 - 977
  • [6] Dose ranging pharmacokinetic trial of high-dose alicaforsen (intercellular adhesion molecule-1 antisense oligodeoxynucleotide) (ISIS 2302) in active Crohn's disease
    Yacyshyn, BR
    Barish, C
    Goff, J
    Dalke, D
    Gaspari, M
    Yu, R
    Tami, J
    Dorr, FA
    Sewell, KL
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (10) : 1761 - 1770
  • [7] Alefacept in subjects with active rheumatoid arthritis.
    Schneider, M
    Stahl, HD
    Scaramucci, J
    Vaishnaw, A
    Podrebarac, T
    Braun, J
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S654 - S654
  • [8] Endothelial function in active rheumatoid arthritis.
    Datta, D
    Ferrell, WR
    Sattar, N
    Sturrock, RD
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S384 - S384
  • [9] Predictive Factors Of Response To Tocilizumab In Patients With Active Rheumatoid Arthritis.
    Victoria Hernandez, Maria
    Narvaez, Javier
    Sanmarti, Raimon
    Reina, Delia
    Diaz-Torne, Cesar
    Magallares, Berta
    Rodriguez de la Serna, Arturo
    Maria Llobet, Jose
    Corominas, Hector
    Miquel Nolla, Joan
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S611 - S611
  • [10] Chondroscopy in patients with rheumatoid arthritis.
    Portek, I
    Lassere, M
    Farmer, K
    Lee, CS
    Shnier, R
    Edmonds, J
    Kirkham, B
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S294 - S294
12345